Cellular Defense May Be Best Offense Against Type 1 Diabetes
"Our goal is to understand the causes of Type
1 diabetes," says TSRI Professor Nora Sarvetnick, who led
a study published in the April issue of the journal Nature
Immunology. "The idea is that we might be able to go on
and design preventive therapies."
Collaboration Reveals Details of Natural Killer T Cells
"We are basically trying to understand how the
NK1.1 system works," says TSRI Associate Professor Luc Teyton,
who has collaborated with Princeton University's Albert Bendelac
to publish a recent Science article characterizing
natural killer T cells.
In the first of a series of articles on the impact of the
Human Genome Project, News&Views asks a number of TSRI investigators
to comment on some of the various programs of research which
follow that historic achievement. These include structural
genomics, functional genomics, comparative genomics, glycomics,
proteomics, positional cloning, and the continued search for
new drug targets.